Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
SELF-FUNDED PLANS Sixty-four percent of covered workers are in a plan that is self-funded, similar to the percentage (67%) last year [Figure 10.1] and [Figure 10.2]
Mechanism of action: melanocortin cAMP/PKA/MITF cascade Presynaptic activation of cutaneous MC1R and central MC3R/MC4R/MC5R PRIMARY PATHWAY MELANOGENESIS MC1R on melanocytes High-affinity binding to the MC1R receptor on epidermal melanocytes
Over 5 monthly sessions, participants saw 26.5% hair regrowth and a 93% reduction in shedding
Your prescribing clinician must weigh the potential benefit against unknown interaction risks when initiating dual therapies
US$ 23.49
US$ 23.47
US$ 29.01
US$ 29.51
US$ 27.04
US$ 26.06
US$ 25.15
US$ 22.15
